Background: Photobiomodulation (PBM) is a well-established, noninvasive therapeutic modality supported by a robust scientific foundation and extensive case studies. Objectives: However, in recent years, researchers have reported that low-intensity light could also help slow down degenerative processes resulting from unbalanced or epigenetically exacerbated aging. Methods: We present data that support the use of PBM in addressing some of the primary degenerative diseases that significantly impact patients' quality of life. Results: Chronic diseases highlight the importance of emerging approaches utilizing low-power light sources, whether applied locally, systemically, or remotely. Conclusions: We conclude that PBM holds significant promise for patients suffering from chronic and debilitating conditions, offering potential therapeutic benefits. As the science of biophotonic continues to evolve, further advancements in light-based therapies are expected to enhance healing processes and improve the quality of life for patients worldwide. The growing body of evidence suggests that PBM is well-prepared to face the challenges imposed by degenerative diseases.
Lizarelli et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: